港股異動 | 都市麗人(2298.HK)大漲逾13% 品牌戰略升級 牽手阿里“犀牛智造”
格隆匯10月6日丨都市麗人(2298.HK)大漲逾13%,暫錄得連續第七週上漲,報0.86港元,盤中高見0.91港元,較8月26日的低點0.42港元已經實現翻倍,最新總市值19億港元。過去一年多都市麗人開始全面升級,升級的重點一是結合市場需求為產品注入黑科技,二是迴歸初心,放大品牌極致性價比優勢。自9月份以來,都市麗人大動作不斷,一方面公司高管開始頻頻增持公司股份,另一方面,阿里巴巴正式發佈祕密研發三年的新業務“犀牛智造”之後,都市麗人也在第一時間牽手新制造平台。格隆匯平台近日發佈研究文章《都市麗人(2298.HK)牽手犀牛智造,高管頻繁增持,加速轉型變革》詳細分析了其投資價值,可點擊鏈接參閲。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.